companydata.dkcompanydata.dk

Sunrise Medical ApS: Financial statements 2022

CVR: 37005665

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

Sunrise Medical ApS (CVR 37005665) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 10,809,487 and a net result of DKK 857,415 compared with DKK -622,033 the year before. That is an increase of 8.2% compared with the year before. Equity in the 2022 report amounted to DKK 3,257,259. The solvency ratio was 21.5%. The company had 16 employees in the financial year.

Gross Profit
DKK 10,809,487
Profit/Loss
DKK 857,415
Equity
DKK 3,257,259
Total Assets
DKK 15,133,113
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-10.8M857K3.3M16
2021-10M-622K2.4M16
2020-8.9M-3.3M3M19
2019-10.9M-2.8M3.5M20
2018-11.5M-2.4M6.3M21

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Sunrise Medical ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Sunrise Medical ApS appoints new auditorMay 24, 2022

As of May 24, 2022, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Sunrise Medical ApS.

Auditor steps down at Sunrise Medical ApSMay 24, 2022

As of May 24, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Sunrise Medical ApS.

About Sunrise Medical ApS

Sunrise Medical ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Adrian John Platt and James Louis Barratt. The board consists of Adrian John Platt (chair) and James Louis Barratt. The company is owned by Cidron Ollopa B.V.. The company has 22 employees (2026). In 2024, the company reported a gross profit of DKK 12,726,030 and a net result of DKK 1,921,194 compared with DKK 1,408,512 the year before. Equity in the 2024 report amounted to DKK 6,586,965.

Source: annual report 2024, Danish Business Authority